Bpca innovative trial designs and assay developments in pediatric therapeutics
Active Awarded Last action
- Contract number
- 75N94023F00004
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,783,682
Award facts
- Contract value 100% obligated
- $8,783,682.00 Current and potential, with all options
- Completion date 77% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27705, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $8,783,682 |
About this award
The National Institute of Child Health and Human Development (NICHD) awarded a delivery order valued at $8.78M to Duke University's Office of Research Administration for Task Order 17 under the Best Pharmaceuticals for Children Act (BPCA) Innovative Trial Designs and Assay Developments in Pediatric Therapeutics program. The contract, which commenced on September 28, 2023, with an ultimate completion date of September 27, 2027, supports the development of innovative clinical trial methodologies and laboratory assays to advance pediatric drug development and therapeutic evaluation. Work will be performed at Duke University's facilities in Durham, North Carolina. This delivery order carries no set-aside designation and utilizes cost-no-fee pricing, indicating a reimbursable structure for eligible costs incurred in service delivery.
This task order is part of Duke University's larger Indefinite Delivery Contract with the National Institute of Allergy and Infectious Diseases valued at approximately $136.6M through September 2035, which encompasses the BPCA Pediatric Trials Network program. Duke University has established itself as a critical partner in federal pediatric research initiatives, leveraging its multidisciplinary expertise in clinical protocol development, pre-clinical studies, formulation development, and Phase 1-3 pediatric clinical trials. The institution's sustained capacity to manage complex research programs involving biologics evaluation and pediatric drug development positions it as a leading provider of innovative trial design services and assay development capabilities in support of national objectives to advance therapeutics for pediatric populations.
Quick answers
Who was awarded contract 75N94023F00004?
75N94023F00004 was awarded to Duke University by National Institute of Child Health and Human Development (National Institutes of Health) on September 28, 2023.
How much is contract 75N94023F00004 worth?
The government has obligated $8,783,682 on 75N94023F00004.
Is contract 75N94023F00004 an order under another contract?
Yes. 75N94023F00004 is a delivery order under 75N94018D00003, an indefinite delivery contract.
Was contract 75N94023F00004 competed?
The extent of competition for 75N94023F00004 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award